Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer
巴替拉西普联合度伐单抗治疗铂类耐药卵巢癌患者的 1b 期临床研究
期刊:iScience
影响因子:4.6
doi:10.1016/j.isci.2024.109801
Anne Knisely, Emily M Hinchcliff, Elisabeth Gardiner, Reshma Rangwala, Kathryn Lito, Bryan Fellman, Ying Yuan, Anil K Sood, Shannon N Westin, Karen H Lu, Amir A Jazaeri